Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS

Circulating Melanoma Cells in Metastatic Patients Treated With Selective BRAF Inhibitors

NCT01878396 ·Status: UNKNOWN

Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases

NCT03754140 ·Status: WITHDRAWN ·Phase: PHASE2

Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma

NCT03964298 ·Status: COMPLETED

A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma

NCT01511913 ·Status: COMPLETED

Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma

NCT03710876 ·Status: COMPLETED ·Phase: PHASE3

Study of Molecular Mechanisms Implicated in the Pathogenesis of Melanoma. Role of Exosomes

NCT02310451 ·Status: COMPLETED ·Phase: NA

Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases

NCT02374242 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies

NCT03673332 ·Status: TERMINATED ·Phase: PHASE4

Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions

NCT05907551 ·Status: UNKNOWN

Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma

NCT02107755 ·Status: COMPLETED ·Phase: PHASE2

Identification of Metabolic Phenotypes Associated With Melanoma Metastasis

NCT06400550 ·Status: RECRUITING

An Observational Study of BRAF Inhibitors Effectiveness in Patients With Newly Diagnosed Metastatic Melanoma

NCT02143999 ·Status: COMPLETED

Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases

NCT05903937 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Triple BRAFinh/MEKinh /antiPD1 Combined Therapy in Patients With BRAF Mutated Melanoma With Central Nervous System Metastasis

NCT05510466 ·Status: UNKNOWN

Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012

NCT03784625 ·Status: COMPLETED ·Phase: EARLY_PHASE1

A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma

NCT01781572 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients

NCT00936221 ·Status: COMPLETED ·Phase: PHASE2

Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain

NCT03605771 ·Status: RECRUITING

Cryoablation+Ipilimumab+Nivolumab in Melanoma

NCT05779423 ·Status: RECRUITING ·Phase: PHASE2

Opdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma

NCT07223411 ·Status: RECRUITING

CP-461 in the Treatment of Patients With Advanced Melanoma

NCT00060710 ·Status: TERMINATED ·Phase: PHASE2

A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma

NCT05234437 ·Status: TERMINATED ·Phase: PHASE2

Tracing Dissemination of Melanoma Cells in Healthy Tissues

NCT02854124 ·Status: COMPLETED

Phase 2 Study of Ipilimumab Plus Dacarbazine in Japanese Patients With Advanced Melanoma

NCT01681212 ·Status: COMPLETED ·Phase: PHASE2

Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients

NCT05615883 ·Status: COMPLETED ·Phase: NA